New York State lawmakers led by Minority Leader Ortt, Sens. Chan, Weber and Martins, launched bills to fix the MTA amid cost ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

Rep. Jim Himes (D-Conn.) is demanding that the Trump administration provide a written explanation of its rationale for firing ...

U.N. Secretary General Antonio Guterres has expressed "full" confidence in South Korea's commitment to democratic principles, ...

Rep. Don Bacon (R-Neb.) criticized President Trump’s ouster of the director of the National Security Agency, arguing that Gen. Timothy Haugh’s firing will hinder the country’s Cyber and Signals ...

The high court said a juror in the multiple-homicide case should not have been removed, even though fellow panelists said he ...

Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...

Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...

Secretary Robert F. Kennedy Jr. won’t acknowledge the scientific consensus that childhood vaccines do not cause autism.  ...

The Constitutional Court’s decision on Friday sealed Yoon’s removal from office four months after he declared martial law, ...

The meeting comes at a time when Yunus’s statement that Northeast India is “landlocked” and Dhaka is the “only guardian of ...

On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst ...